Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 27, 2015 - Issue 7
127
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

HIV patients' decision of switching to second-line antiretroviral therapy in India

Pages 900-906 | Received 04 Jul 2014, Accepted 29 Jan 2015, Published online: 27 Feb 2015

References

  • Aitchison, J., & Brown, J. (1957). The lognormal distribution. Cambridge: Cambridge University Press.
  • Ajose, O., Mookerjee, S., Mills, E. J., Boulle, A., & Ford, N. (2012). Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: A systematic review and meta-analysis. AIDS, 26, 929–938. doi:10.1097/QAD.0b013e328351f5b2
  • Claxton, K. (1999). The irrelevance of inference: A decision-making approach to the stochastic evaluation of health care technologies. Journal of Health Economics, 18, 341–364. doi:10.1016/S0167-6296(98)00039-3
  • Claxton, K., Eggington, S., Ginnelly, L., Griffin, S., McCabe, C., Philips, Z., … Wailoo, A. (2005). A pilot study of value of information analysis to support research recommendations for NICE. Technical report, CHE Research Paper 4. York: Centre for Health Economics, University of York.
  • Cohen, O. (2000). Antiretroviral therapy: Time to think strategically. The Lancet, 132, 320–322.
  • de Mello-Sampayo, F. (2014). The timing and probability of treatment switch under cost uncertainty: An application to patients with gastrointestinal stromal tumor. Value in Health, 17, 215–222. doi:10.1016/j.jval.2013.12.008
  • Dixit, A. (1993). The art of smooth pasting. Fundamentals of Pure and Applied Economics, 55, 1–18.
  • Freedberg, K. A., Kumarasamy, N., Losina, E., Cecelia, A. J., Scott, C. A., Divi, N., … CEPAC-International Investigators. (2007). Clinical impact and cost-effectiveness of antiretroviral therapy in India: Starting criteria and second-line therapy. AIDS, 21(4), S117–S128. doi:10.1097/01.aids.0000279714.60935.a2
  • Gupta, S. B., Pujari, S. N., Joshi, S. R., & Patel, A. K. (2007). API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India. Journal of Association of Physicians of India, 54, 57–74.
  • Harrington, M., & Carpenter, C. C. (2000). Hit HIV-1 hard, but only when necessary. The Lancet, 355, 2147–2152. doi:10.1016/S0140-6736(00)02388-6
  • Ito, K. (1951). On stochastic differential equations. Memoirs, American Mathematical Society, 4, 1–51.
  • Jahn, A., Floyd, S., Crampin, A. C., Mwaungulu, F., Mvula, H., Munthali, F., … Glynn, J. R. (2008). Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. The Lancet, 37, 579–598.
  • Kahn, J. G., Marseille, E., Moore, D., Bunnell, R., Were, W., Degerman, R., … Mermin, J. (2011). CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: Cost effectiveness study. BMJ, 343, d6884. doi:10.1136/bmj.d6884
  • Keebler, D., Revill, P., Braithwaite, S., Phillips, A., Blaser, N., Borquez, A., … Hallett, T. B. (2014). Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: A combined analysis of three mathematical models. The Lancet Global Health, 2(1), e35–e43. doi:10.1016/S2214-109X(13)70048-2
  • Kumarasamy, N., Patel, A., & Pujari, S. (2011). Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to? The Indian Journal of Medical Research, 134, 787–800. doi:10.4103/0971-5916.92626
  • Lasserre, P., Moatti, J.-P., & Soubeyran, A. (2006). Early initiation of highly active antiretroviral therapies for AIDS: Dynamic choice with endogenous and exogenous learning. Journal of Health Economics, 25, 579–598. doi:10.1016/j.jhealeco.2005.09.006
  • Levy, M., & Nir, A. R. (2012). The utility of health and wealth. Journal of Health Economics, 31, 379–392. doi:10.1016/j.jhealeco.2012.02.003
  • Medecins Sans Frontieres (2014). Achieving undetectable: What questions remain in scaling-up HIV virologic treatment monitoring? MSF Undetectable, 6, 1–20.
  • Meyer, E., & Rees, R. (2012). Watchfully waiting: Medical intervention as an optimal investment decision. Journal of Health Economics, 31, 349–358. doi:10.1016/j.jhealeco.2012.02.002
  • Mills, E. J., Bakanda, C., Birungi, J., Chan, K., Ford, N., Cooper, C. L., … Hogg, R. S. (2011). Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: A cohort analysis from Uganda. Annals of Internal Medicine, 155, 209–216. doi:10.7326/0003-4819-155-4-201108160-00358
  • Oksendal, B. (2003). Stochastic differential equations: An introduction with applications. Berlin: Springer.
  • Sculpher, M., & Claxton, K. (2005). Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty – When is there sufficient evidence? Value in Health, 8, 433–446. doi:10.1111/j.1524-4733.2005.00033.x
  • UNAIDS/WHO. (2010). Country progress report, India. Technical report. Geneva: Author. Retrieved May, 2013, from http://www.unaids.org
  • World Health Organization (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. Geneva: Author.
  • World Health Organisation (2014). Supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva: Author.
  • Zivin, J. G., & Neideill, M. (2009). Medical technology adoption, uncertainty, and irreversibilities: Is a bird in the hand really worth more than two in the bush? Health Economics, 19, 142–153.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.